Improving physical activity, sleep and stress-management in cancer patients during and after treatment Other
Conditions
Interventions
This study uses clustered randomisation at the health care organisation (HCO) level. A total of 10 hospital departments, 6 rehabilitation centers and 16 physiotherapy practices will be included in the
Sponsors
Netherlands Organisation for Health Research and Development
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. Patients who are diagnosed with cancer from the moment of diagnosis up until one year after completing the primary treatment for cancer (e.g. radiotherapy, chemotherapy, surgery) 2. Patients undergoing primary treatment for cancer are treated with a curative intent 3. Aged 18 years or older 4. Able to read and speak Dutch 5. Having a PC/tablet and internet
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in the study: 1. Having a serious medical, psychiatric or cognitive disease that would interfere with participation (e.g. Alzheimer’s disease, blindness, severe obesity (BMI=35)) 2. Being in the palliative phase
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Physical activity is measured via the short questionnaire to assess health-enhancing physical activity (SQUASH) at baseline, 3 months and 6 months and via ActiGraph accelerometers at baseline and 6 months. 2. Sleep is measured via the Pittsburgh Sleep Quality Index (PSQI) at baseline, 3 months and 6 months and via ActiGraph accelerometers at baseline and 6 months. 3. Stress is measured via the Perceived Stress Scale (PSS) at baseline, 3 months and 6 months 4. Health-related quality of life is measured via the European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire (EORTC QLQ-C30) at baseline, 3 months and 6 months 5. Fatigue is measured via the Checklist Individual Strength 20 items (CIS20-R) at baseline, 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cost-effectiveness and cost-utility is measured via the IMTA Medical Consumption Questionnaire (iMCQ), the IMTA Productivity Cost Questionnaire (iPCQ) and the EQ-5D-5L questionnaire at 6 months. 2. Amount of accessed intervention modules, duration of use and use of exercises is measured via intervention software log data 3. Intervention rating and appreciation is measured via an online questionnaire at 6 months 4. Use and feasibility of the implementation protocols for embedding the intervention in oncological care by health care professionals is measured via an online questionnaire and semistructured interviews | — |
Countries
Netherlands
Contacts
Public ContactEline Collombon
Outcome results
None listed